Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-07-25 Purchase | 2025-07-30 4:47 pm | ImageneBio Inc. | IMA | Stampacchia Otello Director | 267,556 | $29.9 | $7,999,924 | 455,361 (Indirect Direct) | View |
| 2023-11-07 Purchase | 2023-11-09 8:36 pm | Lexeo Therapeutics Inc. | LXEO | Omega Fund VI L.P. Omega Fund VI GP L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari 10% Owner | 454,545 | $11 | $4,999,995 | 2,157,623 (Direct) | View |
| 2022-03-14 Sale | 2022-03-16 9:54 pm | Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello 10% Owner | 106,500 | $15.55 | $1,656,483 | 9,453,260 (Indirect Direct) | View |
| 2021-11-19 Sale | 2021-11-23 4:53 pm | Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Director 10% Owner | 45,424 | $34.58 | $1,570,679 | 4,763,380 (Direct) | View |
| 2021-11-16 Sale | 2021-11-18 6:30 pm | Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Director 10% Owner | 2,594 | $33.5 | $86,899 | 4,808,804 (Direct) | View |
| 2021-11-16 Sale | 2021-11-18 6:30 pm | Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Director 10% Owner | 2,594 | $33.5 | $86,899 | 4,808,804 (Direct) | View |
| 2021-11-12 Sale | 2021-11-16 1:29 pm | Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Director 10% Owner | 24,017 | $33.66 | $808,412 | 4,811,398 (Direct) | View |
| 2021-11-10 Sale | 2021-11-12 1:08 pm | Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Director 10% Owner | 18,290 | $33.61 | $614,726 | 4,835,415 (Direct) | View |
| 2021-11-08 Sale | 2021-11-10 12:16 pm | Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Director 10% Owner | 11,354 | $33.66 | $382,207 | 4,853,705 (Direct) | View |
| 2021-11-04 Sale | 2021-11-08 2:14 pm | Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Director 10% Owner | 31,015 | $33.57 | $1,041,021 | 4,865,059 (Direct) | View |
| 2021-10-12 Purchase | 2021-10-14 4:40 pm | Theseus Pharmaceuticals Inc. | THRX | Omega Fund VI L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari Former 10% owner | 187,500 | $16 | $3,000,000 | 711,479 (Direct) | View |
| 2021-09-23 Sale | 2021-09-27 8:50 pm | Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Director 10% Owner | 12,171 | $33.58 | $408,702 | 4,896,074 (Direct) | View |
| 2021-09-16 Sale | 2021-09-20 12:53 pm | Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Director 10% Owner | 100,000 | $32.99 | $3,299,009 | 4,908,245 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-07-25 Exercise | 2025-07-30 4:47 pm | N/A 2034-06-07 | ImageneBio Inc. | IMA | Stampacchia Otello Director | 17,899 | $0 | 455,361 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-10 4:15 pm | N/A 2034-06-06 | Ikena Oncology Inc. | IKNA | Stampacchia Otello Director | 17,520 | $0 | 17,520 (Direct) | View |
| 2023-11-07 Conversion | 2023-11-09 8:36 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Omega Fund VI L.P. Omega Fund VI GP L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari 10% Owner | 19,318,610 | $0 | 2,157,623 (Direct) | View |
Ownership | 2023-11-02 9:40 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Omega Fund VI L.P. Omega Fund VI GP L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari 10% Owner | 0 | $0 | 1,662,748 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 4:30 pm | N/A 2033-06-09 | Ikena Oncology Inc. | IKNA | Stampacchia Otello Director | 17,520 | $0 | 17,520 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-29 4:11 pm | N/A 2032-06-21 | Kronos Bio Inc. | KRON | Stampacchia Otello Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 6:21 pm | N/A 2032-06-09 | Ikena Oncology Inc. | IKNA | Stampacchia Otello Director | 13,419 | $0 | 13,419 (Direct) | View |
| 2022-03-14 Exercise | 2022-03-16 9:54 pm | N/A 2030-04-01 | Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello 10% Owner | 16,500 | $0 | 9,453,260 (Indirect) | View |
| 2022-03-14 Exercise | 2022-03-16 9:54 pm | N/A N/A | Replimune Group Inc. | REPL | Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello 10% Owner | 16,500 | $9.78 | 9,453,260 (Indirect) | View |
| 2021-12-21 Option Award | 2021-12-23 6:43 pm | N/A 2031-12-21 | Ikena Oncology Inc. | IKNA | Stampacchia Otello Director | 13,419 | $0 | 13,419 (Direct) | View |
| 2021-10-12 Conversion | 2021-10-14 4:40 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Omega Fund VI L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari Former 10% owner | 1,217,131 | $0 | 711,479 (Direct) | View |
Ownership | 2021-10-06 7:49 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Omega Fund VI L.P. Omega Fund VI GP L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari 10% Owner | 0 | $0 | 523,979 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-23 9:18 pm | N/A 2031-06-21 | Kronos Bio Inc. | KRON | Stampacchia Otello Director 10% Owner | 20,600 | $0 | 20,600 (Direct) | View |